Corcept Therapeutics Incorporated
USD87.89
+0.57 (+0.65%)
CEO
Joseph K. Belanoff
IPO Date
2004-04-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$87.42
Prev. Close
$87.32
Day Low
$87.18
Day High
$87.95
52W Low
$28.66
52W High
$91.00
Market Cap
$9.44B
Volume
0.82M
| 37.2 |
| 31 Dec 2023 | FY | 98.7% | 22.0% | 20.9% | 17.1% | 0.00 | 4.39 | 31.7 |
| 31 Dec 2022 | FY | 98.7% | 25.2% | 20.2% | 17.4% | 0.00 | 6.89 | 21.4 |
| 31 Dec 2021 | FY | 98.6% | 30.7% | 29.9% | 26.6% | 0.00 | 5.60 | 20.4 |
| 31 Dec 2020 | FY | 98.4% | 30.0% | 20.3% | 18.5% | 0.00 | 10.07 | 28.5 |
| 31 Dec 2019 | FY | 98.2% | 30.7% | 25.4% | 22.8% | 0.01 | 7.91 | 14.7 |
| 31 Dec 2018 | FY | 97.9% | 30.0% | 27.3% | 24.2% | 0.00 | 6.72 | 22.3 |
| 31 Dec 2017 | FY | 97.8% | 81.1% | 67.6% | 58.5% | 0.00 | 4.75 | 15.9 |
| 31 Dec 2016 | FY | 97.5% | 10.0% | 19.7% | 11.8% | 0.35 | 2.40 | 98.6 |
| 37.1 |
| 30 Sept 2025 | Q3 | 97.8% | 9.5% | 3.1% | 2.4% | 0.01 | 3.14 | 109.4 |
| 30 Jun 2025 | Q2 | 98.2% | 18.1% | 5.5% | 4.4% | 0.01 | 3.06 | 54.4 |
| 31 Mar 2025 | Q1 | 98.5% | 13.1% | 3.0% | 2.4% | 0.01 | 3.07 | 144.7 |
| 31 Dec 2024 | Q4 | 98.4% | 16.7% | 4.5% | 3.6% | 0.01 | 3.35 | 43.0 |
| 30 Sept 2024 | Q3 | 98.4% | 25.6% | 7.3% | 6.0% | 0.01 | 3.70 | 25.6 |
| 30 Jun 2024 | Q2 | 98.5% | 21.7% | 6.0% | 5.0% | 0.01 | 5.57 | 23.7 |
| 31 Mar 2024 | Q1 | 98.3% | 18.9% | 5.1% | 4.2% | 0.00 | 5.18 | 23.8 |
| 31 Dec 2023 | Q4 | 98.6% | 23.2% | 6.2% | 5.0% | 0.00 | 4.39 | 26.5 |